Target intelligence / Profile preview

Foot-and-mouth disease virus VP1 G-H loop (FMDV VP1 G-H loop)

Target
FMDV VP1 G-H loop
Molecular classification
Viral capsid protein, Antigenic epitope, Protein domain
01

Overview

The Foot-and-mouth disease virus (FMDV) VP1 G-H loop is a highly mobile and solvent-exposed structural element located on the surface of the viral capsid (Logan et al., 1993). It is characterized by a highly conserved Arginine-Glycine-Aspartic acid (RGD) motif, which serves as the primary ligand for host cell integrin receptors, specifically alpha-v beta-6, facilitating viral attachment and subsequent entry (Jackson et al., 2003). In addition to its role in pathogenesis, the G-H loop is the most prominent immunodominant epitope on the FMDV particle, eliciting the production of potent neutralizing antibodies during infection or vaccination (DiMarchi et al., 1986). Due to its exposure, the loop is subject to significant selective pressure, leading to high sequence variability across the seven FMDV serotypes, which complicates the development of universal vaccines. Therapeutic strategies often focus on synthetic peptides or recombinant proteins mimicking this loop to induce protective immunity or using monoclonal antibodies to block the RGD-integrin interaction (Blanco et al., 2013). Because this loop is central to both viral infectivity and the host immune response, it remains the primary target for the design of next-generation FMDV vaccines.

Other names
VP1 G-H loopFMDV RGD loopMajor antigenic site 1 of FMDVVP1 loop epitope
02

Mechanism of action

Neutralization of viral infectivity by blocking the interaction between the viral RGD motif and host cell integrin receptors.

03

Biological functions

Viral attachmentHost cell entryReceptor bindingImmune recognition
04

Disease associations

Foot-and-mouth diseaseInfection
05

Safety considerations

Antigenic variation (drift)Serotype-specific protectionShort duration of immunityPotential for viral escape mutants
06

Interacting drugs

B2T peptide vaccine

3 more in the full profile.

07

Biomarkers

Neutralizing antibody titersVP1-specific IgG levelsIntegrin binding affinityVP1-specific T-cell response

Beyond the preview

Go deeper on Foot-and-mouth disease virus VP1 G-H loop (FMDV VP1 G-H loop).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Foot-and-mouth disease virus VP1 G-H loop (FMDV VP1 G-H loop).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call